Key points are not available for this paper at this time.
Interview with Dr. Thomas Frieden on mandatory reporting of glycosylated hemoglobin values in New York City. (07:22)Download The diabetes epidemic in the United States continues unabated, with a staggering toll in acute and chronic complications, disability, and death. The primary culprits are poor glycemic control over the long term and other major risk factors, such as hypertension, cigarette smoking, obesity, and elevated levels of cholesterol or blood lipids. Although physicians know how to treat diabetes in individual patients, overall progress against the epidemic requires widespread improvement in glycemic control, as underscored by the recent finding that intensive insulin therapy reduces the risk of cardiovascular disease among patients with type 1 diabetes.1 In 2005, an estimated 20.8 million . . .
Robert Steinbrook (Wed,) studied this question.